Physical AI, Quantum, and Bio-Innovation: Inside Canada’s Research Frontier

Summary

Nic Brathwaite asks why Canada generates elite science and engineering research but captures relatively little of the resulting economic value at home. At Waterloo, Mary Wells and Chris Houser argue that co-op education, creator-owned IP, and early commercialization training help convert research into talent, startups, and industry partnerships, while AI trust, regulation, and access to capital remain major bottlenecks. They highlight deep-tech areas such as physical AI, robotics, quantum computing, quantum sensing, additive manufacturing, and bio-compostable materials. At McMaster, Heather Sheardown and Gianni Parise describe a different but equally commercialization-minded model built around problem-based learning, evidence-based medicine, nuclear infrastructure, and bioinnovation. McMaster examples include waste-heat recovery, critical-mineral-free motors, inhaled vaccine delivery, radiopharmaceuticals, and the Fusion Pharmaceuticals spinout, alongside a strong argument that commercialization will become a third core pillar of university strategy.

Notes

• Canada’s core problem is a research-to-product gap: top universities produce strong science, but domestic business investment in commercialization is far below peers.
• The episode frames a founder-retention issue: many venture-backed Canadian founders reportedly relocate to the U.S. after raising meaningful capital.
• Waterloo’s origin story is presented as commercialization-first, with local business and community leaders shaping the institution.
• Waterloo’s IP model keeps intellectual property with the creator, which Mary Wells says attracts ambitious students and faculty who want to commercialize.
• The co-op system is central to Waterloo’s talent engine: theory plus workplace experience is designed into the university model.
• Wells says the co-op pipeline now reaches scale, with 85% of participating students in demand globally.
• Waterloo’s model is not just academic; it is explicitly meant to produce industry-relevant graduates and commercialization-ready researchers.
• Canadian AI skepticism is identified as a commercialization drag, with Wells arguing public trust is lower than in some peer countries.
• Wells argues Canada should invest in deployment layers of AI, especially embodied AI, physical AI, robotics, and automation.
• The conversation repeatedly returns to physical AI as an industrial opportunity, not just generative software.
• Houser argues deep-tech work often needs funding before the application is known, and cites Donna Strickland’s pulsed-laser research as a delayed breakthrough example.
• Houser points to quantum sensors from a startup context as a concrete medical-diagnostics pathway.
• The regulatory bottleneck is specific: he says drug testing rules still force mouse tests before human trials even when organoids may be a better human analog.
• Houser links regulation to translation: policy can slow the path from lab model to human-ready therapeutic.
• A recurring thesis is that Canadian founders believe they need to move south to scale a multi-billion-dollar company.
• Waterloo’s commercialization training is being pushed earlier through ARC, the Academy of Research Commercialization.
• ARC’s first cohort included 30 PhD students, mostly from science and engineering.
• Waterloo is experimenting with an entrepreneurship PhD pathway so founders can keep building while using university infrastructure to solve scientific bottlenecks.
• Houser wants commercialization thinking to influence faculty evaluation, not just student programs.
• Open Quantum Design is described as a global collaboration layer for quantum computing, likened to GitHub for quantum computing.
• Waterloo’s quantum work spans science, engineering, and math, and Houser says it has moved toward industry use.
• Houser says Waterloo’s quantum computing work has moved beyond theory into early-stage industry deployment.
• RoboHub is presented as shared robotics infrastructure, more like a lending library than isolated labs.
• That robotics stack includes autonomous vehicles, social robotics, drones, and flying robots.
• Waterloo is also pushing bio-compostable plastics as an environmental response to plastic pollution.
• Wells says Waterloo’s multiscale additive manufacturing facility is among the world’s top five and can print complex parts from complex materials.
• The additive manufacturing work extends to medical parts and even mushroom- or organic-material containers.
• McMaster is positioned as a comprehensive university spanning health science, engineering, humanities, social sciences, and business.
• McMaster’s signature educational methods are problem-based learning and evidence-based medicine.
• The campus nuclear reactor is highlighted as a distinctive McMaster asset.
• Parise says his own work has focused for two decades on muscle stem cells, muscle growth, and aging.
• Sheardown’s research is in ophthalmic biomaterials, using plastics and devices to improve eye treatment and drug delivery.
• McMaster is pushing commercialization thinking earlier in the research process, rather than at the end.
• Parise predicts commercialization will become a third core pillar of university business over the next decade.
• McMaster’s heat-recovery work uses waste heat from pizza ovens to heat water or other restaurant needs.
• The same thermal-reuse logic is extended to urban infrastructure, such as an ice rink and a neighboring senior citizens’ home.
• At McMaster’s Automotive Resource Center, a lab built motors that avoid critical minerals and are already deployed internationally.
• The motors are described as commercially deployed in motorcycles in India and on Hamilton airport ground vehicles.
• McMaster infectious disease researchers developed an inhaled, needle-free vaccine delivery system that is already in clinical trial.
• Parise frames radiopharmaceuticals as bioinnovation: novel molecules and strategies for difficult-to-treat cancers.
• The McMaster nuclear reactor is described as a uniquely scaled national asset for medical isotopes and research.
• Parise says the reactor produces about 60% of the world’s iodine-125 supply and supports treatment for 70,000 prostate cancer patients per year.
• The reactor enables neutron-based materials characterization through beam lines off the core.
• Parise says roughly 70% of aircraft in Canada have turbine blades characterized through the reactor.
• He says the reactor also matters for energy research, and that nuclear is essential to net zero.
• AstraZeneca’s $2.4 billion acquisition of Fusion Pharmaceuticals is cited as a major Canadian university commercialization outcome.
• Parise says Fusion succeeded despite the commercialization ecosystem, not because it was already strong.
• A Fraunhofer partnership helped create biomedical innovation facilities at Innovation Park, which later gave Fusion a place to move into.
• McMaster has launched a campus-wide review of commercialization assets to coordinate what had been fragmented programs.
• McMaster’s undergraduate students are described as eager for entrepreneurship and innovation programming.
• Sheardown says she uses AI for drafting and tone, but sees much heavier daily use among Silicon Valley engineers.
• Parise argues AI should be adopted with ethical guardrails, but it will ultimately speed up research.
• Sheardown thinks AI can help graduate students by saving time on literature review.
• Parise says AI is unavoidable and should be integrated into academic programs and research.
• Sheardown argues AI should be constrained by guardrails and human oversight to avoid technically impossible or catastrophic designs.
• Parise urges urgent support for sovereign AI and domestic data-center capacity in Canada.
• Sheardown says future education should move away from lectures and exams toward hands-on experiential learning.
• Parise says McMaster aims to redefine the university as a lever for economic development and community integration.